TG/HDL-C ratio | Q1 (≤ 1.32) | Q2 (1.32 to ≤ 2.11) | Q3 (2.11 to ≤ 3.56) | Q4 (> 3.56) | P-value |
---|---|---|---|---|---|
Participants | 2539 | 2542 | 2542 | 2541 | Â |
Gender | < 0.001b | ||||
 Male | 1317 (51.87%) | 1173 (46.14%)a | 1126 (44.30%)a | 1130 (44.47%)a |  |
 Female | 1222 (48.13%) | 1369 (53.86%) | 1416 (55.70%) | 1411 (55.53%) |  |
Age (years) | 59.89 ± 9.76 | 59.32 ± 9.48a | 59.04 ± 9.11a | 58.45 ± 8.96a | < 0.001d |
Drinking status | < 0.001b | ||||
 Never drinkers | 312 (12.29%) | 350 (13.77%)a | 378 (14.87%)a | 344 (13.54%)a |  |
 Ever drinkers | 1398 (55.06%) | 1580 (62.16%) | 1609 (63.30%) | 1633 (64.27%) |  |
 Current drinkers | 829 (32.65%) | 612 (24.08%) | 555 (21.83%) | 564 (22.20%) |  |
Smoking status | < 0.001b | ||||
 Never smokers | 1469 (57.86%) | 1571 (61.80%)a | 1605 (63.14%)a | 1605 (63.16%)a |  |
 Ever smokers | 221 (8.70%) | 204 (8.03%) | 217 (8.54%) | 240 (9.45%) |  |
 Current smokers | 849 (33.44%) | 767 (30.17%) | 720 (28.32%) | 696 (27.39%) |  |
Physical activity | < 0.001b | ||||
 No | 790 (31.11%) | 896 (35.25%)a | 945 (37.18%)a | 962 (37.86%)a |  |
 Yes | 1749 (68.89%) | 1646 (64.75%) | 1597 (62.82%) | 1579 (62.14%) |  |
Drugs for cardiovascular prevention | < 0.001b | ||||
 No | 2379 (93.70%) | 2359 (92.80%) | 2338 (91.97%)a | 2280 (89.73%)a |  |
 Yes | 160 (6.30%) | 183 (7.20%) | 204 (8.03%) | 261 (10.27%) |  |
Hypertension | < 0.001b | ||||
 No | 1678 (66.09%) | 1589 (62.51%)a | 1409 (55.43%)a | 1249 (49.15%)a |  |
 Yes | 861 (33.91%) | 953 (37.49%) | 1133 (44.57%) | 1292 (50.85%) |  |
SBP (mmHg) | 128.03 ± 21.01 | 129.23 ± 20.94a | 131.77 ± 21.70a | 133.32 ± 21.31a | 0.011d |
DBP (mmHg) | 73.98 ± 12.04 | 74.83 ± 11.71a | 76.45 ± 12.15a | 77.98 ± 12.01a | < 0.001d |
BMI (kg/m2) | 22.08 ± 3.42 | 22.98 ± 3.83a | 24.00 ± 3.95a | 25.04 ± 3.89a | < 0.001d |
TG/HDL-C ratio | 0.96 ± 0.23 | 1.69 ± 0.23a | 2.73 ± 0.41a | 6.41 ± 3.13a | < 0.001d |
HDL-C (mg/dL) | 67.26 ± 14.34 | 54.13 ± 10.12a | 46.88 ± 8.66a | 37.56 ± 7.91a | < 0.001d |
TG (mg/dL) | 62.59 ± 15.09 | 91.13 ± 18.44a | 127.07 ± 26.02a | 229.07 ± 89.30a |  < 0.001d |
LDL-C (mg/dL) | 111.06 ± 29.89 | 119.04 ± 32.66a | 123.42 ± 34.41a | 113.94 ± 37.98a | < 0.001d |
TC (mg/dL) | 188.07 ± 34.74 | 189.16 ± 36.70 | 194.14 ± 37.53a | 200.17 ± 41.83a | < 0.001d |
CRP (mg/L) | 0.75 (0.44–1.74) | 0.91 (0.52–1.88)a | 1.08 (0.58–2.25)a | 1.32 (0.72–2.63)a | < 0.001c |
Scr (mg/dL) | 0.78 ± 0.32 | 0.77 ± 0.22 | 0.78 ± 0.20 | 0.80 ± 0.20a | < 0.001d |
FPG (mg/dL) | 102.23 ± 23.48 | 105.34 ± 28.41a | 109.09 ± 34.61a | 120.99 ± 45.84a | < 0.001d |
HbA1c (%) | 5.13 ± 0.61 | 5.19 ± 0.70a | 5.25 ± 0.82a | 5.40 ± 0.98a | < 0.001d |
Cystatin C (mg/L) | 1.01 ± 0.31 | 1.03 ± 0.27 | 1.01 ± 0.27 | 0.96 ± 0.26a | < 0.001d |
UA (mg/dL) | 4.24 ± 1.16 | 4.32 ± 1.22a | 4.45 ± 1.24a | 4.79 ± 1.31a | < 0.001d |